Results 241 to 250 of about 585,044 (300)
Lipoprotein apheresis: still needed in many patients, or soon a historical practice? [PDF]
Clin Kidney JSchettler VJJ +3 more
europepmc +1 more source
Lipid Immunometabolism in Autoimmune Rheumatic Diseases: Mechanistic Links Between Chronic Inflammation, Lipoprotein Dysfunction and Cardiovascular Risk. [PDF]
Biology (Basel)Bonanni L, Ferri N.
europepmc +1 more source
Triglyceride-glucose index is associated with the severity of coronary artery disease. [PDF]
PLoS OneWang D +9 more
europepmc +1 more source
Association of the cholesterol-high-density lipoprotein-glucose index with coronary atherosclerotic burden in patients with coronary artery disease. [PDF]
Front NutrZhang J, Dong H, Lei S, Lu Y.
europepmc +1 more source
Cardiovascular and Metabolic Outcomes of Hormone Replacement Therapy in Women Aged 65 Years and Older: A Systematic Review of Randomized Clinical Trials. [PDF]
Clin PharmacolMousavi T +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Endocrinology and Metabolism Clinics of North America, 2015
Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients ...
Patrick M, Moriarty, Linda, Hemphill
openaire +3 more sources
Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients ...
Patrick M, Moriarty, Linda, Hemphill
openaire +3 more sources
Baillière's Clinical Endocrinology and Metabolism, 1995
Lipoprotein (a) is similar to low-density lipoprotein but is unique in having an additional apolipoprotein called apolipoprotein (a) (apo(a)) covalently linked to it. apo(a), which is a member of the plasminogen gene superfamily, has a protease domain which cannot be activated to cause fibrinolysis.
openaire +2 more sources
Lipoprotein (a) is similar to low-density lipoprotein but is unique in having an additional apolipoprotein called apolipoprotein (a) (apo(a)) covalently linked to it. apo(a), which is a member of the plasminogen gene superfamily, has a protease domain which cannot be activated to cause fibrinolysis.
openaire +2 more sources
The Biochemistry of Lipoproteins
Journal of Inherited Metabolic Disease, 1988SummaryLipids are transported in the blood in four major classes of lipoproteins. The triacylglycerol‐rich lipoproteins are chylomicrons and very‐low‐density lipoproteins (VLDL) which are produced by the small intestine and liver, respectively. These lipoproteins mainly carry fatty acids to adipose tissue and muscle where the triacylglycerol is ...
A M, Salter, D N, Brindley
openaire +2 more sources
Lipoproteins and Lipoprotein Lipase
Comprehensive Physiology, 1985Abstract The sections in this article are: History Lipoproteins Chylomicrons Very‐Low‐Density Lipoproteins
Margit Hamosh, Paul Hamosh
openaire +1 more source